Many Patients With Locally Advanced Rectal Cancer Can Forgo Pelvic Radiation
In the phase 3 PROSPECT trial, patients with locally advanced rectal cancer had similar outcomes if they received pelvic chemoradiation or if they received FOLFOX with chemoradiation added only in select cases.